October 2020
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

There are over two hundred different forms of cancer that attack the tissues, bones, and organs of the human body.

This impacts all types of people, from childhood to old age.

Scientists and doctors are constantly working to find new diagnostic tools and treatments that can identify and more effectively treat this devastating disease.

In most areas of life, we look to preventative medicine to be far more effective than any other course of treatment or management that has been made available.

If we are already suffering, then a patient needs the medicine to not only rid one’s body of the destructive element, but to heal the body as well.

Current Cancer medications, either focus on destroying the cancer cells, or it tries to make the body as healthy as possible so that it can destroy the cells by more natural means.

Many people look into the stages of the disease because it helps doctors and patients determine or describe the severity of the disease, how much it has spread, and the location(s) of cancer that is present.

What are the Stages of Cancer?

Stage 0 means that the mutated cells are only located at the original site of the growth. This is the most treatable stage.

Stage 1 is when the mutated cells begin to infiltrate the inner tissue of the organ or bone that they are growing on.

Stage 2 is when a tumor begins to form within the bone, organ or tissue.

Stage 3 includes cancerous cells that begin to attach to the nearby lymph nodes. At this stage, not only would the tumor be removed but the lymph nodes would be considered as well.

Stage 4 is the highest level and, as suspected, it is when the cancerous cells have begun to spread throughout the body to other organs and tissue.

Knowing the 5 stages, they can be proactive in determining their treatment options for their coping, for their survival and for their healing process now and throughout their lives.

The stages refer to the degree to which the disease has attacked their bodies.

Patients want to know as much as they can so that they can wrap their minds around what can be done at this point. They don’t want to feel like they are underestimating their strength or oversimplifying what their options are for their future.

It is difficult to treat, but with all of the research and advances in treatment, medications, and surgery, there is always hope.

Support and resources are available for each patient to help them confront the reality that he or she now faces.

Comments are closed.

Special Procedures

Click on Any Topic

Bone Marrow Transplants

Organ Transplants

Stem Cells

——————————————–

Euthanasia

Physician Assisted Suicide

Medical Topics
  • Long-Term Data Back Anti-PD-1 in Advanced Non-Squamous NSCLC
    (MedPage Today) -- Long-term data from an early first-line trial of pembrolizumab (Keytruda) plus chemotherapy showed that more than half of patients with advanced non-squamous non-small cell lung cancer (NSCLC) remained alive at 3 years. In cohort...
  • Suze Orman's Schwannoma
    (MedPage Today) -- Financial advisor, author and former CNBC host Suze Orman has always stressed that it is a mistake for people to ignore their money problems. Now she wants you to know that "the most vital and stupid mistake I could ever make...
  • 'License' to Smoke After Negative Lung Screening?
    (MedPage Today) -- Some individuals appear to interpret a negative low-dose CT (LDCT) lung screening scan as a green light to resume smoking, a post hoc analysis of the National Lung Screening Trial (NLST) found. For example, highly nicotine dependent...
  • Hunting Resistance Mechanisms in RET-Fusion Lung Cancer
    (MedPage Today) -- As detected by circulating tumor DNA (ctDNA), acquired resistance to pralsetinib (Gavreto) in RET fusion-positive lung cancer was relatively uncommon, findings from the ARROW study suggested. In 42 non-small cell lung cancer...
  • Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC
    (MedPage Today) -- A first-line immune checkpoint inhibitor combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) improved survival in patients with advanced non-small cell lung cancer (NSCLC) when added to a limited course of chemotherapy...
Content Protected Using Blog Protector By: PcDrome.